Overview

Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Pasteurized Breast Milk for Preterm Infants

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy in preterm infants following treatment with BSSL when administered in pasteurized breast milk.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Swedish Orphan Biovitrum
Criteria
Inclusion Criteria:

- Preterm infants

- less than or equal to 32 weeks of gestational age

- appropriate for gestational age

- enterally fed with pasteurized breast milk